From human and animal studies, we do understand some of the major biological consequences of head impacts that may pave the ...

Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...

AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...

An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer’s Disease. For the first time, scientists have ...

Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can ...

Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...

An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...

The benefits do not stop there. Recent studies suggest GLP-1 drugs may also reduce the risk of heart disease, kidney disease and stroke, and even possibly protect the brain from AD by reducing ...

A team of researchers has reported a significant advance in Alzheimer’s treatment. Their candidate drug, RI-AG03, attacks the ...

An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.

In people with Alzheimer's disease, they clump together, starve brain cells of nutrients and slow down signals in the organ ...